Widely debated IVF add-on does not increase clinical pregnancy rates, according to new retrospective research.
Genome editing reactivates an embryonic gene to help compensate for missing alpha-globin in preclinical research into alpha-thalassaemia.
An AI model could help estimate the risk of miscarriage after IVF, using data routinely collected during treatment.